img

Global Paediatric Spasticity Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Paediatric Spasticity Treatment Market Research Report 2024

Pediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When pediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movement and speech. 
According to MRAResearch’s new survey, global Paediatric Spasticity Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Paediatric Spasticity Treatment market research.
Key companies engaged in the Paediatric Spasticity Treatment industry include Allergan, Ipsen Biopharmaceuticals, Almirall, Roche, Sanofi, Saol Therapeutics and US WorldMeds, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Paediatric Spasticity Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Paediatric Spasticity Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Paediatric Spasticity Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Ipsen Biopharmaceuticals
Almirall
Roche
Sanofi
Saol Therapeutics
US WorldMeds
Segment by Type
Drug Treatment
Surgical Treatment

Segment by Application


Hospital
Clinic
Emergency Sugical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Paediatric Spasticity Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Spasticity Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Paediatric Spasticity Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Emergency Sugical Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paediatric Spasticity Treatment Market Perspective (2018-2033)
2.2 Paediatric Spasticity Treatment Growth Trends by Region
2.2.1 Global Paediatric Spasticity Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Paediatric Spasticity Treatment Historic Market Size by Region (2018-2023)
2.2.3 Paediatric Spasticity Treatment Forecasted Market Size by Region (2024-2033)
2.3 Paediatric Spasticity Treatment Market Dynamics
2.3.1 Paediatric Spasticity Treatment Industry Trends
2.3.2 Paediatric Spasticity Treatment Market Drivers
2.3.3 Paediatric Spasticity Treatment Market Challenges
2.3.4 Paediatric Spasticity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paediatric Spasticity Treatment Players by Revenue
3.1.1 Global Top Paediatric Spasticity Treatment Players by Revenue (2018-2023)
3.1.2 Global Paediatric Spasticity Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Paediatric Spasticity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paediatric Spasticity Treatment Revenue
3.4 Global Paediatric Spasticity Treatment Market Concentration Ratio
3.4.1 Global Paediatric Spasticity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Spasticity Treatment Revenue in 2022
3.5 Paediatric Spasticity Treatment Key Players Head office and Area Served
3.6 Key Players Paediatric Spasticity Treatment Product Solution and Service
3.7 Date of Enter into Paediatric Spasticity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paediatric Spasticity Treatment Breakdown Data by Type
4.1 Global Paediatric Spasticity Treatment Historic Market Size by Type (2018-2023)
4.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Type (2024-2033)
5 Paediatric Spasticity Treatment Breakdown Data by Application
5.1 Global Paediatric Spasticity Treatment Historic Market Size by Application (2018-2023)
5.2 Global Paediatric Spasticity Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Paediatric Spasticity Treatment Market Size (2018-2033)
6.2 North America Paediatric Spasticity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Paediatric Spasticity Treatment Market Size by Country (2018-2023)
6.4 North America Paediatric Spasticity Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paediatric Spasticity Treatment Market Size (2018-2033)
7.2 Europe Paediatric Spasticity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Paediatric Spasticity Treatment Market Size by Country (2018-2023)
7.4 Europe Paediatric Spasticity Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paediatric Spasticity Treatment Market Size (2018-2033)
8.2 Asia-Pacific Paediatric Spasticity Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Paediatric Spasticity Treatment Market Size (2018-2033)
9.2 Latin America Paediatric Spasticity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Paediatric Spasticity Treatment Market Size by Country (2018-2023)
9.4 Latin America Paediatric Spasticity Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paediatric Spasticity Treatment Market Size (2018-2033)
10.2 Middle East & Africa Paediatric Spasticity Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Paediatric Spasticity Treatment Introduction
11.1.4 Allergan Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Ipsen Biopharmaceuticals
11.2.1 Ipsen Biopharmaceuticals Company Detail
11.2.2 Ipsen Biopharmaceuticals Business Overview
11.2.3 Ipsen Biopharmaceuticals Paediatric Spasticity Treatment Introduction
11.2.4 Ipsen Biopharmaceuticals Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.2.5 Ipsen Biopharmaceuticals Recent Development
11.3 Almirall
11.3.1 Almirall Company Detail
11.3.2 Almirall Business Overview
11.3.3 Almirall Paediatric Spasticity Treatment Introduction
11.3.4 Almirall Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.3.5 Almirall Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Paediatric Spasticity Treatment Introduction
11.4.4 Roche Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Paediatric Spasticity Treatment Introduction
11.5.4 Sanofi Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Saol Therapeutics
11.6.1 Saol Therapeutics Company Detail
11.6.2 Saol Therapeutics Business Overview
11.6.3 Saol Therapeutics Paediatric Spasticity Treatment Introduction
11.6.4 Saol Therapeutics Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.6.5 Saol Therapeutics Recent Development
11.7 US WorldMeds
11.7.1 US WorldMeds Company Detail
11.7.2 US WorldMeds Business Overview
11.7.3 US WorldMeds Paediatric Spasticity Treatment Introduction
11.7.4 US WorldMeds Revenue in Paediatric Spasticity Treatment Business (2018-2023)
11.7.5 US WorldMeds Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Paediatric Spasticity Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Paediatric Spasticity Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Paediatric Spasticity Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Paediatric Spasticity Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Paediatric Spasticity Treatment Market Share by Region (2018-2023)
Table 8. Global Paediatric Spasticity Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Paediatric Spasticity Treatment Market Share by Region (2024-2033)
Table 10. Paediatric Spasticity Treatment Market Trends
Table 11. Paediatric Spasticity Treatment Market Drivers
Table 12. Paediatric Spasticity Treatment Market Challenges
Table 13. Paediatric Spasticity Treatment Market Restraints
Table 14. Global Paediatric Spasticity Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Paediatric Spasticity Treatment Market Share by Players (2018-2023)
Table 16. Global Top Paediatric Spasticity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Spasticity Treatment as of 2022)
Table 17. Ranking of Global Top Paediatric Spasticity Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Paediatric Spasticity Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Paediatric Spasticity Treatment Product Solution and Service
Table 21. Date of Enter into Paediatric Spasticity Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Paediatric Spasticity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Paediatric Spasticity Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Paediatric Spasticity Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Paediatric Spasticity Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Paediatric Spasticity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Paediatric Spasticity Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Paediatric Spasticity Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Paediatric Spasticity Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Paediatric Spasticity Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Paediatric Spasticity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Paediatric Spasticity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Paediatric Spasticity Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Paediatric Spasticity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Paediatric Spasticity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Paediatric Spasticity Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Paediatric Spasticity Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Paediatric Spasticity Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Paediatric Spasticity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Paediatric Spasticity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Paediatric Spasticity Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Paediatric Spasticity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Allergan Company Detail
Table 47. Allergan Business Overview
Table 48. Allergan Paediatric Spasticity Treatment Product
Table 49. Allergan Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 50. Allergan Recent Development
Table 51. Ipsen Biopharmaceuticals Company Detail
Table 52. Ipsen Biopharmaceuticals Business Overview
Table 53. Ipsen Biopharmaceuticals Paediatric Spasticity Treatment Product
Table 54. Ipsen Biopharmaceuticals Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 55. Ipsen Biopharmaceuticals Recent Development
Table 56. Almirall Company Detail
Table 57. Almirall Business Overview
Table 58. Almirall Paediatric Spasticity Treatment Product
Table 59. Almirall Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 60. Almirall Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Paediatric Spasticity Treatment Product
Table 64. Roche Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Sanofi Company Detail
Table 67. Sanofi Business Overview
Table 68. Sanofi Paediatric Spasticity Treatment Product
Table 69. Sanofi Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Saol Therapeutics Company Detail
Table 72. Saol Therapeutics Business Overview
Table 73. Saol Therapeutics Paediatric Spasticity Treatment Product
Table 74. Saol Therapeutics Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 75. Saol Therapeutics Recent Development
Table 76. US WorldMeds Company Detail
Table 77. US WorldMeds Business Overview
Table 78. US WorldMeds Paediatric Spasticity Treatment Product
Table 79. US WorldMeds Revenue in Paediatric Spasticity Treatment Business (2018-2023) & (US$ Million)
Table 80. US WorldMeds Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paediatric Spasticity Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Paediatric Spasticity Treatment Market Share by Type: 2022 VS 2033
Figure 3. Drug Treatment Features
Figure 4. Surgical Treatment Features
Figure 5. Global Paediatric Spasticity Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Paediatric Spasticity Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Emergency Sugical Center Case Studies
Figure 10. Others Case Studies
Figure 11. Paediatric Spasticity Treatment Report Years Considered
Figure 12. Global Paediatric Spasticity Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Paediatric Spasticity Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Paediatric Spasticity Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Paediatric Spasticity Treatment Market Share by Players in 2022
Figure 16. Global Top Paediatric Spasticity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Spasticity Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Paediatric Spasticity Treatment Revenue in 2022
Figure 18. North America Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Paediatric Spasticity Treatment Market Share by Country (2018-2033)
Figure 20. United States Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Paediatric Spasticity Treatment Market Share by Country (2018-2033)
Figure 24. Germany Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Paediatric Spasticity Treatment Market Share by Region (2018-2033)
Figure 32. China Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Paediatric Spasticity Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Paediatric Spasticity Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Paediatric Spasticity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Allergan Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 47. Ipsen Biopharmaceuticals Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 48. Almirall Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 51. Saol Therapeutics Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 52. US WorldMeds Revenue Growth Rate in Paediatric Spasticity Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed